NCT02237053View on ClinicalTrials.gov

Effects of Glucagon Administration on Energy Expenditure

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2016

Conditions
HyperglucagonemiaObesity
Interventions
DRUG

Glucagon

DRUG

Octreotide

BEHAVIORAL

Placebo

DRUG

Insulin

Trial Locations (1)

32804

Florida Hospital Translational Research Institute for Metabolism and Diabetes, Orlando

All Listed Sponsors
lead

AdventHealth Translational Research Institute

OTHER

NCT02237053 - Effects of Glucagon Administration on Energy Expenditure | Biotech Hunter | Biotech Hunter